Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institute of Microchemical Technology is a Japan-based microfluidics and microchemical chip company that develops, manufactures, and sells glass-based microchemical chips, related accessories, and custom microchemical systems. The company appears to operate primarily as a tools and platform provider rather than a therapeutics developer, serving applications across chemistry, biotechnology, medicine, clinical diagnostics, environmental monitoring, food, and agriculture. IMT also offers consultation and contract research for integrating chip-based reaction control, fluid handling, detection, separation, extraction, and culture workflows. Its technology is positioned as an enabling platform for miniaturized chemical analysis, synthesis, and diagnostic device development. The company has also collaborated with Panasonic on glass-molded mass-production technology for microfluidic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Microchemical Technology.